Valentina Favorito

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Atomic Force Microscopy

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Expert opinion on emerging drugs

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Favorito, Ilaria Ricciotti, Andrea De Giglio, Laura Fabbri, Renata Seminerio, Alessandro Di Federico, Eleonora Gariazzo, Silvia Costabile, Giulio Metro
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies. Expert opinion on emerging drugs (2024)
Valentina Favorito, Ilaria Ricciotti, Andrea De Giglio, Laura Fabbri, Renata Seminerio, Alessandro Di Federico, Eleonora Gariazzo, Silvia Costabile, Giulio Metro
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies. Expert opinion on emerging drugs 29 (2) (2024)
Valentina Favorito, Ilaria Ricciotti, Andrea De Giglio, Laura Fabbri, Renata Seminerio, Alessandro Di Federico, Eleonora Gariazzo, Silvia Costabile, Giulio Metro
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies. Expert opinion on emerging drugs 29 (2) (2024)
Valentina Favorito, Ilaria Ricciotti, Andrea De Giglio, Laura Fabbri, Renata Seminerio, Alessandro Di Federico, Eleonora Gariazzo, Silvia Costabile, Giulio Metro
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies. Expert opinion on emerging drugs 29 (2) (2024)
Valentina Favorito, Ilaria Ricciotti, Andrea De Giglio, Laura Fabbri, Renata Seminerio, Alessandro Di Federico, Eleonora Gariazzo, Silvia Costabile, Giulio Metro
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies. Expert opinion on emerging drugs (2024)
Mirta Mosca, Nicole Conci, Alessandro Di Federico, Valentina Tateo, Valentina Favorito, Arianna Zappi, Francesco Gelsomino, Andrea De Giglio
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis. JCO precision oncology 7 (2023)